Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenues
Operating Expenses:
Personnel costs	262,625	122,458
Research and development expenses, related party	15,267	13,097
Professional fees	672,655	448,806
Impairment loss		340,231
General and administrative expenses	96,431	60,198
Total operating expenses	1,046,978	984,790
Loss from operations	(1,046,978)	(984,790)
Other Expenses:
Interest expense	(19,969)
Financing costs	(115,165)
Total other expenses	(135,134)
Loss before income taxes	(1,182,112)	(984,790)
Income taxes
Net loss	(1,182,112)	(984,790)
Deemed dividend on warrant modification		(3,548)
Net loss available to common stockholders	$ (1,182,112)	$ (988,338)
Net loss per common share:
Basic	$ (0.03)	$ (0.03)
Diluted	$ (0.03)	$ (0.03)
Weighted average common shares outstanding:
Basic	34,548,676	30,577,988
Diluted	34,548,676	30,577,988